{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T23:09:24Z","timestamp":1772665764996,"version":"3.50.1"},"reference-count":38,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2014,11,24]],"date-time":"2014-11-24T00:00:00Z","timestamp":1416787200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0113162","type":"journal-article","created":{"date-parts":[[2014,11,24]],"date-time":"2014-11-24T18:48:12Z","timestamp":1416854892000},"page":"e113162","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":12,"title":["Assessing the Effect of Treatment Duration on the Association between Anti-Diabetic Medication and Cancer Risk"],"prefix":"10.1371","volume":"9","author":[{"given":"Anna","family":"But","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haining","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satu","family":"M\u00e4nnist\u00f6","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eero","family":"Pukkala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jari","family":"Haukka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,11,24]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1007\/s00125-012-2525-1","article-title":"Diabetes and cancer (1): evaluating the temporal relationship between type 2 diabetes and cancer incidence","volume":"55","author":"J Johnson","year":"2012","journal-title":"Diabetologia"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1007\/s00125-012-2526-0","article-title":"Diabetes and cancer (2): evaluating the impact of diabetes on mortality in patients with cancer","volume":"55","author":"AG Renehan","year":"2012","journal-title":"Diabetologia"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"675","DOI":"10.4158\/EP13248.CS","article-title":"Diabetes and Cancer\u2014An AACE\/ACE Consensus Statement","volume":"19","author":"Y Handelsman","year":"2013","journal-title":"Endocrine Practice"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.2337\/dc12-0788","article-title":"Metformin and the risk of cancer: time-related biases in observational studies","volume":"35","author":"S Suissa","year":"2012","journal-title":"Diabetes Care"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1016\/j.ejca.2014.04.032","article-title":"Diabetes and cancer: 5 years into the recent controversy","volume":"50","author":"E Badrick","year":"2014","journal-title":"Eur J Cancer"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Gandini S, Puntoni M, Heckman-Stoddard BM, Dunn BK, Ford L, <etal>et al<\/etal>.. (2014) Metformin and Cancer Risk and Mortality: A Systematic Review and Meta-analysis Taking into Account Biases and Confounders. Cancer Prev Res. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/cancerpreventionresearch.aacrjournals.org\/content\/early\/2014\/08\/06\/1940-6207.CAPR-13-0424\" xlink:type=\"simple\">http:\/\/cancerpreventionresearch.aacrjournals.org\/content\/early\/2014\/08\/06\/1940-6207.CAPR-13-0424<\/ext-link>. Accessed 25 August 2014.","DOI":"10.1158\/1940-6207.CAPR-13-0424"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1007\/s00125-011-2381-4","article-title":"Cancer occurrence in Danish diabetic patients: duration and insulin effects","volume":"55","author":"B Carstensen","year":"2012","journal-title":"Diabetologia"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"e000433","DOI":"10.1136\/bmjopen-2011-000433","article-title":"Risk of cancer in patients using glucose-lowering agents: a nationwide cohort study of 3.6 million people","volume":"2","author":"C Andersson","year":"2012","journal-title":"BMJ Open"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S2213-8587(13)70028-7","article-title":"Diabetes treatments and cancer risk: the importance of considering aspects of drug exposure","volume":"1","author":"JJ Walker","year":"2013","journal-title":"The Lancet Diabetes & Endocrinology"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1093\/ije\/dyp330","article-title":"Thirty-five-year trends in cardiovascular risk factors in Finland","volume":"39","author":"E Vartiainen","year":"2010","journal-title":"Int J Epidemiol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1093\/ije\/30.suppl_1.S35","article-title":"Trends in coronary risk factors in the WHO MONICA project","volume":"30","author":"A Evans","year":"2001","journal-title":"Int J Epidemiol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1600-0463.1997.tb05617.x","article-title":"Summary of avoidable cancers in the Nordic countries","volume":"105","author":"JH Olsen","year":"1997","journal-title":"APMIS"},{"key":"ref13"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"365","DOI":"10.3109\/02841869409098430","article-title":"Data quality and quality control of a population-based cancer registry. Experience in Finland","volume":"33","author":"L Teppo","year":"1994","journal-title":"Acta Oncol"},{"key":"ref15","volume":"11.","unstructured":"Klaukka T (2001) The Finnish database on drug utilisation. Norsk epidemiologi <volume>11.<\/volume> Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.ntnu.no\/ojs\/index.php\/norepid\/article\/view\/529\" xlink:type=\"simple\">https:\/\/www.ntnu.no\/ojs\/index.php\/norepid\/article\/view\/529<\/ext-link>. Accessed 2014 Jan 23."},{"key":"ref16"},{"key":"ref17","unstructured":"Carstensen B (2012) DCRC: Tabulation outline. Steno Diabetes Center, Gentofte, Denmark <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.bendixcarstensen.com\/DCRC\/Tabulate\/tabulate.pdf\" xlink:type=\"simple\">http:\/\/www.bendixcarstensen.com\/DCRC\/Tabulate\/tabulate.pdf<\/ext-link>: Diabetes and Cancer Reasearch Consortium. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.bendixcarstensen.com\/DCRC\/Tabulate\/tabulate.pdf\" xlink:type=\"simple\">http:\/\/www.bendixcarstensen.com\/DCRC\/Tabulate\/tabulate.pdf<\/ext-link>."},{"key":"ref18","unstructured":"Carstensen B, Plummer M, Laara E, Hills M (2008) Epi: A package for statistical analysis in epidemiology. R package version 1."},{"key":"ref19","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1007\/s00125-011-2242-1","article-title":"Time-varying incidence of cancer after the onset of type 2 diabetes: evidence of potential detection bias","volume":"54","author":"JA Johnson","year":"2011","journal-title":"Diabetologia"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"3953","DOI":"10.2337\/dc13-0140","article-title":"Cohort study of insulin glargine and risk of breast, prostate, and colorectal cancer among patients with diabetes","volume":"36","author":"LA Habel","year":"2013","journal-title":"Diabetes Care"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Onitilo AA, Stankowski RV, Berg RL, Engel JM, Glurich I, <etal>et al<\/etal>.. (2013) Type 2 diabetes mellitus, glycemic control, and cancer risk. Eur J Cancer Prev. doi: 10.1097\/CEJ.0b013e3283656394.","DOI":"10.1097\/CEJ.0b013e3283656394"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.2337\/diacare.27.5.1047","article-title":"Global prevalence of diabetes: estimates for the year 2000 and projections for 2030","volume":"27","author":"S Wild","year":"2004","journal-title":"Diabetes Care"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/S0140-6736(06)68770-9","article-title":"Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data","volume":"367","author":"AD Lopez","year":"2006","journal-title":"Lancet"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"302.e1","DOI":"10.1016\/j.amjmed.2011.07.033","article-title":"Patterns of medication initiation in newly diagnosed diabetes mellitus: quality and cost implications","volume":"125","author":"NR Desai","year":"2012","journal-title":"Am J Med"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/ijc.24803","article-title":"Incident cancer burden attributable to excess body mass index in 30 European countries","volume":"126","author":"AG Renehan","year":"2010","journal-title":"Int J Cancer"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/0002-9343(92)90621-H","article-title":"Smoking and cancer","volume":"93","author":"D Carbone","year":"1992","journal-title":"The American Journal of Medicine"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1001\/jama.298.22.2654","article-title":"Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis","volume":"298","author":"C Willi","year":"2007","journal-title":"JAMA"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/978-1-4614-5441-0_18","article-title":"Pancreatic cancer and diabetes","volume":"771","author":"M Morrison","year":"2012","journal-title":"Adv Exp Med Biol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.2337\/dc13-0045","article-title":"Detection bias and overestimation of bladder cancer risk in type 2 diabetes: a matched cohort study","volume":"36","author":"IN Colmers","year":"2013","journal-title":"Diabetes Care"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1007\/s00125-011-2390-3","article-title":"Glucose-lowering agents and the patterns of risk for cancer: a study with the General Practice Research Database and secondary care data","volume":"55","author":"TP Van Staa","year":"2012","journal-title":"Diabetologia"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.amjmed.2013.06.009","article-title":"Options for combination therapy in type 2 diabetes: comparison of the ADA\/EASD position statement and AACE\/ACE algorithm","volume":"126","author":"T Bailey","year":"2013","journal-title":"Am J Med"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"327","DOI":"10.4158\/endp.19.2.a38267720403k242","article-title":"AACE comprehensive diabetes management algorithm 2013","volume":"19","author":"AJ Garber","year":"2013","journal-title":"Endocr Pract"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1007\/s00125-010-1796-7","article-title":"Diabetes, prediabetes and cancer mortality","volume":"53","author":"XH Zhou","year":"2010","journal-title":"Diabetologia"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/S0140-6736(09)60619-X","article-title":"Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study","volume":"373","author":"AG Tab\u00e1k","year":"2009","journal-title":"Lancet"},{"key":"ref35","unstructured":"Niemi M, Winell K (2006) Diabetes in Finland. Prevalence and variations in quality of care Tampere: Finnish Diabetes Association. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.diabetes.fi\/files\/1105\/Diabetes_in_Finland._Prevalence_and_Variation_in_Quality_of_Care.pdf\" xlink:type=\"simple\">http:\/\/www.diabetes.fi\/files\/1105\/Diabetes_in_Finland._Prevalence_and_Variation_in_Quality_of_Care.pdf<\/ext-link>. Accessed 24 January 2014."},{"key":"ref36","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/j.1464-5491.2011.03250.x","article-title":"A first national prevalence estimate of diagnosed and undiagnosed diabetes in France in 18- to 74-year-old individuals: the French Nutrition and Health Survey 2006\/2007","volume":"28","author":"C Bonaldi","year":"2011","journal-title":"Diabetic Medicine"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1136\/bmj.331.7518.656-a","article-title":"Quarter of people with diabetes in England are undiagnosed","volume":"331","author":"S Mayor","year":"2005","journal-title":"BMJ"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2337\/diacare.26.1.61","article-title":"Age- and Sex-Specific Prevalences of Diabetes and Impaired Glucose Regulation in 13 European Cohorts1","volume":"26","year":"2003","journal-title":"Dia Care"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0113162","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T03:39:59Z","timestamp":1588995599000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0113162"}},"subtitle":[],"editor":[{"given":"Michael","family":"Scheurer","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,11,24]]},"references-count":38,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2014,11,24]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0113162","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,24]]}}}